IFNβ-1b
Showing 1 - 25 of >10,000
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Rochester (VSV-IFNß-NIS, Pembrolizumab)
Recruiting
- Solid Tumor
- +2 more
- VSV-IFNβ-NIS
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic
Sep 26, 2022
COVID-19 Virus Infection Trial in Milano (Interferon-ß-1a, Standard of Care (SOC))
Terminated
- COVID-19 Virus Infection
- Interferon-ß-1a
- Standard of Care (SOC)
-
Milano, ItalyIRCCS Ospedale San Raffaele
Apr 28, 2021
Biospecimen in Pediatric Patients and Adult Guardians Diagnosed
Recruiting
- Glycogen Storage Disease Type IB
- Specimen Donation
-
Woburn, MassachusettsSanguine BioSciences, Inc.
Jun 22, 2023
Relapsed/Refractory Large B-cell Lymphoma Trial (KITE-197, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Relapsed/Refractory Large B-cell Lymphoma
- KITE-197
- +2 more
- (no location specified)
Oct 6, 2023
Pulmonary Sarcoidosis Trial (XTMAB-16 or Placebo)
Not yet recruiting
- Pulmonary Sarcoidosis
- XTMAB-16 or Placebo
- (no location specified)
May 25, 2023
Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)
Recruiting
- Chronic Inducible Urticaria
- Oral EP262
-
Tampa, Florida
- +5 more
Sep 18, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)
Not yet recruiting
- Acute Myeloid Leukemia
-
Houston, TexasMD Anderson Cancer Center
Oct 27, 2023
Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)
Not yet recruiting
- Healthy
- H107e
- +10 more
-
Pretoria, Gauteng, South AfricaAurum Institute
Sep 24, 2023
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Aug 2, 2023
Leprosy Trial in Rio de Janeiro (LEP-F1 + GLA-SE, Placebo)
Not yet recruiting
- Leprosy
- LEP-F1 + GLA-SE
- Placebo
-
Rio de Janeiro, BrazilVeronica Schmitz Pereira
Dec 5, 2022
Diabetes, Type 1 Trial in Valencia (Aerobic, High-intensity interval training)
Completed
- Diabetes Mellitus, Type 1
- Aerobic
- High-intensity interval training
-
Valencia, SpainRodrigo Martin-San Agustin
Oct 17, 2023
Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)
Recruiting
- Relapsed/Refractory Large B-Cell Lymphoma
- Prizloncabtagene autoleucel
-
Beijing, China
- +1 more
Mar 24, 2023
Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain
Recruiting
- Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
- Quantitative Real Time Polymerase chain reaction (qRT-PCR)
- ELISA and colorimeter
-
Assiut, EgyptBiochemistry department,Faculty of medicine
Oct 10, 2023
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)
Not yet recruiting
- Chronic Hepatitis b
- AB-101
- +2 more
-
Auckland, New ZealandNew Zealand Clinical Research Auckland
Jul 26, 2023
Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)
Recruiting
- Chronic Hepatitis B
- VRON-0200-AdC6
- VRON-0200-AdC7
-
Hong Kong, Hong Kong
- +1 more
Oct 6, 2023
Alcohol Use Disorder Trial in Glendale (DCR-AUD, Placebo)
Active, not recruiting
- Alcohol Use Disorder
- DCR-AUD
- Placebo
-
Glendale, CaliforniaParexel Los Angeles Early Phase Clinical Unit
Apr 26, 2023
Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)
Completed
- Cancer
- Neoplasm
- NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
-
Frankfurt, GermanyKrankenhaus Nordwest
Oct 3, 2022
NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)
Not yet recruiting
- Non-Small Cell Lung Cancer
- +3 more
- HMBD-001
- +3 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 16, 2023
Relapsed/ Refractory Multiple Myeloma Trial (GC012F)
Not yet recruiting
- Relapsed/ Refractory Multiple Myeloma
- GC012F
- (no location specified)
Apr 28, 2023
Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)
Not yet recruiting
- Ulcerative Colitis
- APL-1401
- Placebo
-
Whittier, CaliforniaNew Hope Research Development
Feb 15, 2023